| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |